Topics

Companies Related to "Many psychiatric disorders have heightened impulsivity" [Most Relevant Company Matches] RSS

07:45 EST 21st January 2020 | BioPortfolio

Here are the most relevant search results for "Many psychiatric disorders have heightened impulsivity" found in our extensive corporate database of over 50,000 company records.

Showing "Many psychiatric disorders have heightened impulsivity" Companies 1–25 of 1,200+

Relevant

American Psychiatric Nurses Association

The American Psychiatric Nurses Association is a national professional membership organization committed to the specialty practice of psychiatric-mental health nursing and wellness promotion, prevention of mental health problems and the care and treatment of persons with psychiatric disorders. APNA’s membership is inclusive of all psychiatric m...


Lundbeck Limited

As a pharmaceutical manufacturer, Lundbeck is unique in that we focus solely on the treatment of diseases of the central nervous system. Our aim is to be the world leader in the development of pharmaceuticals for psychiatric and neurological disorders, and are pioneers of new treatments and new approaches.As specialists, our research and development is focused and concentrated. As specialists, we ...

Psychiatric Solutions, Inc. (PSI)

Psychiatric Solutions, Inc. offers an extensive continuum of behavioral health programs to critically ill children, adolescents and adults and is the largest operator of owned or leased freestanding psychiatric inpatient facilities with more than 11,000 beds in 32 states, Puerto Rico and the U.S. Virgin Islands. PSI also manages freestanding psychiatric in...


Neuronetics

Neuronetics is focused on successfully developing and commercializing noninvasive therapies to treat significant, chronic psychiatric and neurological disorders. We are committed to working collaboratively with the clinical community to improve care, at reasonable cost, for the many patients suffering from these disorders.

Motac

Motac Neuroscience provides highly-specialised services for the pharmaceutical and biotechnology industries to support the discovery and development of therapeutics for neurological and psychiatric disorders. Motac personnel have extensive expertise in neurodegenerative conditions, particularly Parkinson's disease and other movement disorders.Motac also has an intellectual property portfolio prote...

Psychiatric Solutions, Inc.

Psychiatric Solutions, Inc. offers an extensive continuum of behavioral health programs to critically ill children, adolescents and adults and is the largest operator of owned or leased freestanding psychiatric inpatient facilities with more than 11,000 beds in 32 states, Puerto Rico and the U.S. Virgin Islands. PSI also manages freestanding psychiatric in...

Cortex Pharmaceuticals, Inc.

Cortex, located in Irvine, California, is a neuroscience company focused on novel drug therapies for treating psychiatric disorders, neurological diseases and sleep apnea. Cortex is pioneering a class of proprietary pharmaceuticals called AMPAKINE® compounds, which act to increase the strength of signals at connections between brain cells. The loss of t...

Laxdale Limited

Psychiatric and CNS diseases, including schizophrenia, bipolar disorders, depression and alzheimer's disease.

Psychiatric Times

As the No. 1 psychiatric multimedia platform in the United States, Psychiatric Times® delivers relevant, up-to-date information to practicing psychiatrists and other health professionals. Additionally, this digital resource provides timely clinical commentary, and practical information that includes peer-reviewed in-depth coverage in monthly special rep...

ICN Pharmaceuticals Incorporated

ICN Pharmaceuticals distributes and sells a broad range of prescription (or "ethical") and OTC pharmaceutical and nutritional products in over 90 countries. These pharmaceutical products treat viral and bacterial infections, diseases of the skin, neuromuscular disorders, cancer, cardiovascular disease, diabetes and psychiatric disorders.

Azevan Pharmaceuticals, Inc.

Azevan Pharmaceuticals, Inc. (Azevan or the Company) is developing novel therapeutics for the treatment of disorders of stress, mood, and behavior. The Company leverages its expertise in behavioral neurobiology with its proprietary chemistry platform targeting G-protein coupled receptors (GPCRs) to create drug candidates. Azevan’s first series of clinical candidates selectively block the effects...

Meadows Behavioral Healthcare

The Meadows Behavioral Healthcare system is a network of specialized behavioral healthcare programs, individualized addiction recovery centers, and acute psychiatric care centers located throughout the United States. Meadows Behavioral Healthcare is the industry leader in providing evidence-based healthcare treatment for people struggling with emotional tr...

PsychoGenics Inc.

PsychoGenics is a leader in preclinical behavioral neurobiology. The Company applies its behavioral expertise together with advances in robotics, computer vision, and informatics to provide innovative solutions for central nervous system drug discovery. PsychoGenics works with pharmaceutical and biotechnology companies, academic institutions, and not-for-p...

Psychiatric Medical Care, LLC

Founded in 2003 and based in Nashville, TN, Psychiatric Medical Care (PMC) is a leading behavioral healthcare management company focused on addressing the needs of rural and underserved communities. Operating in more than 20 states, the company manages both inpatient psychiatry units and intensive outpatient psychiatry programs within hospitals. PMC also provides telepsychiatry services across a ...

Marinus Pharmaceuticals

Marinus is a dynamic pharmaceuticals company dedicated to the discovery, development, and commercialization of drugs to treat serious neurological, psychiatric, and pain disorders.

Clinical Insights

Clinical Insights was established in 1996 as an independent clinical trial center specializing in Phase II, III, and IV psychopharmacological research. The mission of Clinical Insights is to become the gold standard in psychopharmacological clinical trials. Our Principal Investigator, Lawrence W. Adler, MD, has participated in the conduct of numerous clinical trials in psychiatric disorders since...

Remuda Ranch, Programs for Eating and Anxiety Disorders

Remuda Ranch offers inpatient and residential programs for individuals of all faiths suffering from eating or anxiety disorders. Each patient is treated by a multi-disciplinary team including a Psychiatric and a Primary Care Provider, Registered Dietitian, Masters Level therapist, Psychologist and Registered Nurse. The professional staff equips each patient with the right tools to live a healthy,...

Alzheon Inc.

Alzheon, Inc. is committed to developing innovative medicines for patients suffering from Alzheimer’s disease and other neurological and psychiatric disorders. Our lead clinical candidate, ALZ-801, is a first-in-class, oral inhibitor of amyloid aggregation and neurotoxicity - hallmarks of Alzheimer’s disease. ALZ-801 is an optimized, novel prodru...

Somaxon Pharmaceuticals

Somaxon is a specialty pharmaceutical company focused on the in-licensing and development of proprietary product candidates for the treatment of diseases and disorders in the fields of psychiatry and neurology.To date, we have in-licensed three products. Our lead product, SILENOR™ (doxepin HCl), is in Phase III clinical trials for the treatment of insomnia. Our product nalmefene HCl is in a Phas...

Redpin Therapeutics

Based in NYC, Redpin Therapeutics is advancing novel platform technologies that enable the non-invasive, targeted regulation of neuronal cell activity in the brain. Leveraging its technologies, Redpin aims to treat both neurological and psychiatric disorders that do not respond to current therapies.

Xention Discovery Ltd

Ion channels influence a multitude of physiological processes from the generation of electrical activity in nerves involved in sensory and motor functions in the brain, to the control of contractile activity in heart, skeletal, and smooth muscle, to nutrient uptake, hormone secretion, cell replication and development and immune cell function.The importance of ion channels in disease pathology is w...

H. Lundbeck A/S

We are a research-based company. We engage in research to find new drugs for treatment of CNS disorders, includ­ing depression, schizophrenia, Alzheimer’s disease and Parkinson’s disease.These are serious disorders. They affect not only patients, but also their families and friends. Besides the stress of having a CNS disorder, patients are often exposed to prejudice because, in many sections ...

Psylin Neurosciences, Inc.

Psylin Neurosciences, Inc. was formed in January, 2007 as a 50/50 joint venture biotechnology company spun out of Amylin Pharmaceuticals, Inc. and PsychoGenics, Inc. Psylin's mission is to pioneer the development of peptide therapeutics in neuropsychiatric disorders. Psylin has access to molecules in Amylin's PHORMOL library and to PsychoGenics' proprietary drug discovery technologies. Amylin's e...

Dey Pharma L.P.

Dey Pharma, L.P., a subsidiary of Mylan Inc. (Nasdaq: MYL), is a specialty pharmaceutical company focused on the development, manufacturing and marketing of prescription drug products for the treatment of respiratory diseases, severe allergic reactions and psychiatric disorders. The company puts patients first and facilitates efficient, cost-effective partnerships with customers. For more informat...

Avera Pharmaceuticals, Inc

Avera Pharmaceuticals, Inc. (San Diego, CA) is an emerging pharmaceutical company focused on the acquisition, development and commercialization of novel pharmaceutical compounds in the neuroscience therapeutics arena.Avera's mission is to identify opportunities for therapeutic advances in the treatment of neurologic and psychiatric disorders, and to license and develop compounds that can meet thes...


More From BioPortfolio on "Many psychiatric disorders have heightened impulsivity"

Quick Search

Corporate Database Quicklinks